SIMILAR PATTERNS OF AMINO ACIDS FOR 6FGD_A_ACTA810

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a04 NITRATE/NITRITE
RESPONSE REGULATOR
PROTEIN NARL


(Escherichia
coli)
PF00072
(Response_reg)
PF00196
(GerE)
3 LEU A 180
LEU A 166
ARG A 179
None
0.68A 6fgdA-1a04A:
3.8
6fgdA-1a04A:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1et6 SUPERANTIGEN SMEZ-2

(Streptococcus
pyogenes)
PF01123
(Stap_Strp_toxin)
PF02876
(Stap_Strp_tox_C)
3 LEU A 141
LEU A 174
ARG A 138
None
0.65A 6fgdA-1et6A:
undetectable
6fgdA-1et6A:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1et9 SUPERANTIGEN SPE-H

(Streptococcus
pyogenes)
PF01123
(Stap_Strp_toxin)
PF02876
(Stap_Strp_tox_C)
3 LEU A 138
LEU A 171
ARG A 135
None
0.61A 6fgdA-1et9A:
undetectable
6fgdA-1et9A:
18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fcu HYALURONOGLUCOSAMINI
DASE


(Apis mellifera)
PF01630
(Glyco_hydro_56)
3 LEU A 314
LEU A  27
ARG A 317
None
0.64A 6fgdA-1fcuA:
undetectable
6fgdA-1fcuA:
24.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kea POSSIBLE G-T
MISMATCHES REPAIR
ENZYME


(Methanothermobacter
thermautotrophicus)
PF00730
(HhH-GPD)
3 LEU A 134
LEU A 187
ARG A  30
None
0.68A 6fgdA-1keaA:
undetectable
6fgdA-1keaA:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kej TERMINAL
DEOXYNUCLEOTIDYLTRAN
SFERASE SHORT
ISOFORM


(Mus musculus)
PF10391
(DNA_pol_lambd_f)
PF14716
(HHH_8)
PF14791
(DNA_pol_B_thumb)
PF14792
(DNA_pol_B_palm)
3 LEU A 460
LEU A 448
ARG A 508
None
0.51A 6fgdA-1kejA:
2.0
6fgdA-1kejA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m4v SET3,
SUPERANTIGEN-LIKE
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 148
LEU A 178
ARG A 145
None
0.62A 6fgdA-1m4vA:
undetectable
6fgdA-1m4vA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nf2 PHOSPHATASE

(Thermotoga
maritima)
PF08282
(Hydrolase_3)
3 LEU A 198
LEU A  72
ARG A 201
None
0.65A 6fgdA-1nf2A:
0.0
6fgdA-1nf2A:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nfp LUXF GENE PRODUCT

(Photobacterium
leiognathi)
PF00296
(Bac_luciferase)
3 LEU A  93
LEU A  68
ARG A 127
None
0.49A 6fgdA-1nfpA:
undetectable
6fgdA-1nfpA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u0t INORGANIC
POLYPHOSPHATE/ATP-NA
D KINASE


(Mycobacterium
tuberculosis)
PF01513
(NAD_kinase)
3 LEU A 141
LEU A 139
ARG A 274
None
0.66A 6fgdA-1u0tA:
3.4
6fgdA-1u0tA:
23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v1p EXOTOXIN 1

(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 153
LEU A 183
ARG A 150
None
0.68A 6fgdA-1v1pA:
undetectable
6fgdA-1v1pA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vb3 THREONINE SYNTHASE

(Escherichia
coli)
PF00291
(PALP)
PF14821
(Thr_synth_N)
3 LEU A 264
LEU A  47
ARG A 238
None
0.66A 6fgdA-1vb3A:
undetectable
6fgdA-1vb3A:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vhe AMINOPEPTIDASE/GLUCA
NASE HOMOLOG


(Bacillus
subtilis)
PF05343
(Peptidase_M42)
3 LEU A 176
LEU A   8
ARG A 333
None
0.68A 6fgdA-1vheA:
3.7
6fgdA-1vheA:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w6f ARYLAMINE
N-ACETYLTRANSFERASE


(Mycolicibacterium
smegmatis)
PF00797
(Acetyltransf_2)
3 LEU A  84
LEU A   5
ARG A  17
None
0.58A 6fgdA-1w6fA:
undetectable
6fgdA-1w6fA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xee CHEMOTAXIS-INHIBITIN
G PROTEIN CHIPS


(Staphylococcus
aureus)
PF11434
(CHIPS)
3 LEU A  49
LEU A  76
ARG A  46
None
0.65A 6fgdA-1xeeA:
undetectable
6fgdA-1xeeA:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zg5 NITRATE/NITRITE
RESPONSE REGULATOR
PROTEIN NARL


(Escherichia
coli)
PF00196
(GerE)
3 LEU A 180
LEU A 166
ARG A 179
None
0.68A 6fgdA-1zg5A:
undetectable
6fgdA-1zg5A:
10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2f EXOCYST COMPLEX
COMPONENT SEC15


(Drosophila
melanogaster)
PF04091
(Sec15)
3 LEU X 302
LEU X 297
ARG X 248
None
0.66A 6fgdA-2a2fX:
undetectable
6fgdA-2a2fX:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b7u CHARYBDIN

(Drimia maritima)
PF00161
(RIP)
3 LEU A 158
LEU A 111
ARG A 154
None
0.67A 6fgdA-2b7uA:
undetectable
6fgdA-2b7uA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dw4 LYSINE-SPECIFIC
HISTONE DEMETHYLASE
1


(Homo sapiens)
PF01593
(Amino_oxidase)
PF04433
(SWIRM)
3 LEU A 261
LEU A 183
ARG A 214
None
0.54A 6fgdA-2dw4A:
4.8
6fgdA-2dw4A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e6k TRANSKETOLASE

(Thermus
thermophilus)
PF00456
(Transketolase_N)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
3 LEU A 335
LEU A 338
ARG A 503
None
0.66A 6fgdA-2e6kA:
4.4
6fgdA-2e6kA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e7a TUMOR NECROSIS
FACTOR


(Homo sapiens)
PF00229
(TNF)
3 LEU A 132
LEU A 126
ARG A  82
None
0.66A 6fgdA-2e7aA:
undetectable
6fgdA-2e7aA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fuq HEPARINASE II
PROTEIN


(Pedobacter
heparinus)
PF07940
(Hepar_II_III)
PF16332
(DUF4962)
3 LEU A 697
LEU A 550
ARG A 700
None
0.56A 6fgdA-2fuqA:
undetectable
6fgdA-2fuqA:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g9h EXTRACELLULAR
ENTEROTOXIN TYPE I


(Staphylococcus
aureus)
PF01123
(Stap_Strp_toxin)
PF02876
(Stap_Strp_tox_C)
3 LEU D 133
LEU D 180
ARG D 130
None
0.67A 6fgdA-2g9hD:
undetectable
6fgdA-2g9hD:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ihm DNA POLYMERASE MU

(Mus musculus)
PF10391
(DNA_pol_lambd_f)
PF14716
(HHH_8)
PF14791
(DNA_pol_B_thumb)
PF14792
(DNA_pol_B_palm)
3 LEU A 446
LEU A 434
ARG A 494
None
0.61A 6fgdA-2ihmA:
undetectable
6fgdA-2ihmA:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jfd FATTY ACID SYNTHASE

(Homo sapiens)
PF00698
(Acyl_transf_1)
PF16197
(KAsynt_C_assoc)
3 LEU A 513
LEU A 793
ARG A 512
None
0.67A 6fgdA-2jfdA:
undetectable
6fgdA-2jfdA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2msw RESPONSE
REGULATOR/SENSOR
HISTIDINE KINASE


(Erythrobacter
litoralis)
PF00072
(Response_reg)
3 LEU A  72
LEU A  45
ARG A  75
None
0.67A 6fgdA-2mswA:
4.8
6fgdA-2mswA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ntt STAPHYLOCOCCAL
ENTEROTOXIN K


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
3 LEU A 133
LEU A 180
ARG A 130
None
0.61A 6fgdA-2nttA:
undetectable
6fgdA-2nttA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nx9 OXALOACETATE
DECARBOXYLASE 2,
SUBUNIT ALPHA


(Vibrio cholerae)
PF00682
(HMGL-like)
PF02436
(PYC_OADA)
3 LEU A 325
LEU A 305
ARG A 294
None
0.55A 6fgdA-2nx9A:
undetectable
6fgdA-2nx9A:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o74 OHCU DECARBOXYLASE

(Danio rerio)
PF09349
(OHCU_decarbox)
3 LEU A 125
LEU A 160
ARG A 124
None
0.53A 6fgdA-2o74A:
undetectable
6fgdA-2o74A:
17.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r4i UNCHARACTERIZED
PROTEIN


(Cytophaga
hutchinsonii)
PF14534
(DUF4440)
3 LEU A  30
LEU A  14
ARG A 102
None
0.47A 6fgdA-2r4iA:
undetectable
6fgdA-2r4iA:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r9z GLUTATHIONE AMIDE
REDUCTASE


(Marichromatium
gracile)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
3 LEU A 362
LEU A 353
ARG A 361
None
0.65A 6fgdA-2r9zA:
4.9
6fgdA-2r9zA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rdg SUPERANTIGEN-LIKE
PROTEIN 11


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 141
LEU A 171
ARG A 138
None
0.58A 6fgdA-2rdgA:
undetectable
6fgdA-2rdgA:
18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rjt BETA-KETOACYL-ACP
SYNTHASE II


(Streptococcus
pneumoniae)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
3 LEU A  96
LEU A  91
ARG A 249
None
0.57A 6fgdA-2rjtA:
undetectable
6fgdA-2rjtA:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2tnf PROTEIN (TUMOR
NECROSIS FACTOR
ALPHA)


(Mus musculus)
PF00229
(TNF)
3 LEU A 132
LEU A 126
ARG A  82
None
0.61A 6fgdA-2tnfA:
undetectable
6fgdA-2tnfA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vi7 ACETYLTRANSFERASE
PA1377


(Pseudomonas
aeruginosa)
PF00583
(Acetyltransf_1)
3 LEU A  61
LEU A  59
ARG A  12
None
0.63A 6fgdA-2vi7A:
2.2
6fgdA-2vi7A:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wvl MANNOSYL-3-PHOSPHOGL
YCERATE SYNTHASE


(Thermus
thermophilus)
PF09488
(Osmo_MPGsynth)
3 LEU A  17
LEU A 275
ARG A 198
None
0.60A 6fgdA-2wvlA:
undetectable
6fgdA-2wvlA:
23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3chl ALPHA-14 GIARDIN

(Giardia
intestinalis)
PF00191
(Annexin)
3 LEU A  32
LEU A  67
ARG A  29
None
0.57A 6fgdA-3chlA:
undetectable
6fgdA-3chlA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cp8 TRNA URIDINE
5-CARBOXYMETHYLAMINO
METHYL MODIFICATION
ENZYME GIDA


(Chlorobaculum
tepidum)
PF01134
(GIDA)
PF13932
(GIDA_assoc)
3 LEU A 615
LEU A 579
ARG A 618
None
0.63A 6fgdA-3cp8A:
3.4
6fgdA-3cp8A:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dao PUTATIVE PHOSPHATE

([Eubacterium]
rectale)
PF08282
(Hydrolase_3)
3 LEU A  62
LEU A  78
ARG A 203
None
0.65A 6fgdA-3daoA:
2.4
6fgdA-3daoA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dcf TRANSCRIPTIONAL
REGULATOR OF THE
TETR/ACRR FAMILY


(Thermobifida
fusca)
PF00440
(TetR_N)
3 LEU A 110
LEU A 157
ARG A 106
None
0.59A 6fgdA-3dcfA:
undetectable
6fgdA-3dcfA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fsd NTF2-LIKE PROTEIN OF
UNKNOWN FUNCTION IN
NUTRIENT UPTAKE


(Rhodospirillum
rubrum)
PF14534
(DUF4440)
3 LEU A  38
LEU A  22
ARG A 111
None
0.60A 6fgdA-3fsdA:
undetectable
6fgdA-3fsdA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hwc CHLOROPHENOL-4-MONOO
XYGENASE COMPONENT 2


(Burkholderia
cepacia)
PF03241
(HpaB)
PF11794
(HpaB_N)
3 LEU A3306
LEU A3430
ARG A3299
None
0.50A 6fgdA-3hwcA:
undetectable
6fgdA-3hwcA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jc7 DNA REPLICATION
COMPLEX GINS PROTEIN
SLD5


(Saccharomyces
cerevisiae)
PF05916
(Sld5)
PF16922
(SLD5_C)
3 LEU D 136
LEU D  87
ARG D  90
None
0.63A 6fgdA-3jc7D:
undetectable
6fgdA-3jc7D:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l3b ES1 FAMILY PROTEIN

(Ehrlichia
chaffeensis)
PF01965
(DJ-1_PfpI)
3 LEU A  25
LEU A 200
ARG A  21
None
0.52A 6fgdA-3l3bA:
3.3
6fgdA-3l3bA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o13 SUPERANTIGEN-LIKE
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 172
LEU A 202
ARG A 169
None
0.64A 6fgdA-3o13A:
undetectable
6fgdA-3o13A:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3of4 NITROREDUCTASE

(Idiomarina
loihiensis)
PF00881
(Nitroreductase)
3 LEU A 102
LEU A  96
ARG A 100
None
None
GOL  A 317 (-3.0A)
0.67A 6fgdA-3of4A:
undetectable
6fgdA-3of4A:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q10 PANTOATE--BETA-ALANI
NE LIGASE


(Yersinia pestis)
PF02569
(Pantoate_ligase)
3 LEU A 254
LEU A 282
ARG A 220
None
0.51A 6fgdA-3q10A:
2.5
6fgdA-3q10A:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q98 TRANSCARBAMYLASE

(Escherichia
coli)
PF00185
(OTCace)
PF02729
(OTCace_N)
3 LEU A 293
LEU A 285
ARG A 281
None
0.57A 6fgdA-3q98A:
4.2
6fgdA-3q98A:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r2i EXOTOXIN 5

(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 176
LEU A 206
ARG A 173
None
0.64A 6fgdA-3r2iA:
undetectable
6fgdA-3r2iA:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r2t PUTATIVE
UNCHARACTERIZED
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 176
LEU A 206
ARG A 173
None
0.62A 6fgdA-3r2tA:
undetectable
6fgdA-3r2tA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rim TRANSKETOLASE

(Mycobacterium
tuberculosis)
PF00456
(Transketolase_N)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
3 LEU A 395
LEU A 537
ARG A 458
None
0.67A 6fgdA-3rimA:
2.3
6fgdA-3rimA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3smt HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD3


(Homo sapiens)
PF00856
(SET)
PF09273
(Rubis-subs-bind)
3 LEU A 160
LEU A 178
ARG A 253
None
None
SAM  A1000 (-2.7A)
0.68A 6fgdA-3smtA:
undetectable
6fgdA-3smtA:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u4y UNCHARACTERIZED
PROTEIN


(Desulfotomaculum
acetoxidans)
PF10282
(Lactonase)
3 LEU A 141
LEU A 139
ARG A 152
None
0.65A 6fgdA-3u4yA:
undetectable
6fgdA-3u4yA:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ury EXOTOXIN

(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 253
LEU A 282
ARG A 250
None
0.67A 6fgdA-3uryA:
undetectable
6fgdA-3uryA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v7n THREONINE SYNTHASE

(Burkholderia
thailandensis)
PF00291
(PALP)
PF14821
(Thr_synth_N)
3 LEU A 104
LEU A 114
ARG A  91
None
0.66A 6fgdA-3v7nA:
undetectable
6fgdA-3v7nA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b9d SERINE/THREONINE-PRO
TEIN KINASE NEK1


(Homo sapiens)
PF00069
(Pkinase)
3 LEU A  88
LEU A 136
ARG A  91
None
0.65A 6fgdA-4b9dA:
undetectable
6fgdA-4b9dA:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4da5 CHOLINE KINASE ALPHA

(Homo sapiens)
PF01633
(Choline_kinase)
3 LEU A 414
LEU A 292
ARG A 411
None
0.60A 6fgdA-4da5A:
undetectable
6fgdA-4da5A:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g34 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3


(Homo sapiens)
PF00069
(Pkinase)
3 LEU A1017
LEU A 914
ARG A 910
None
0.63A 6fgdA-4g34A:
undetectable
6fgdA-4g34A:
20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iwn TRNA
(CMO5U34)-METHYLTRAN
SFERASE


(Escherichia
coli)
PF13649
(Methyltransf_25)
3 LEU A 146
LEU A 138
ARG A 119
None
None
GEK  A 301 ( 3.6A)
0.68A 6fgdA-4iwnA:
2.4
6fgdA-4iwnA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m9x CELL DEATH PROTEIN 4

(Caenorhabditis
elegans)
PF00619
(CARD)
PF00931
(NB-ARC)
3 LEU A 239
LEU A 211
ARG A 242
None
0.61A 6fgdA-4m9xA:
2.0
6fgdA-4m9xA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mgg MUCONATE LACTONIZING
ENZYME


(Labrenzia
aggregata)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
3 LEU A 264
LEU A 307
ARG A 279
None
0.55A 6fgdA-4mggA:
undetectable
6fgdA-4mggA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnb OBCA, OXALATE
BIOSYNTHETIC
COMPONENT A


(Burkholderia
glumae)
PF05853
(BKACE)
3 LEU A 423
LEU A 408
ARG A 419
None
0.58A 6fgdA-4nnbA:
undetectable
6fgdA-4nnbA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nv7 ARYLAMINE
N-ACETYLTRANSFERASE


(Mesorhizobium
japonicum)
PF00797
(Acetyltransf_2)
3 LEU A  87
LEU A   9
ARG A  22
None
0.66A 6fgdA-4nv7A:
undetectable
6fgdA-4nv7A:
22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ohj TOXIC SHOCK SYNDROME
TOXIN-1


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
3 LEU A 177
LEU A 208
ARG A 174
None
0.66A 6fgdA-4ohjA:
undetectable
6fgdA-4ohjA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q2b ENDO-1,4-BETA-D-GLUC
ANASE


(Pseudomonas
putida)
PF01270
(Glyco_hydro_8)
3 LEU A 156
LEU A 164
ARG A 154
None
0.63A 6fgdA-4q2bA:
undetectable
6fgdA-4q2bA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qjy GH127
BETA-L-ARABINOFURANO
SIDASE


(Geobacillus
stearothermophilus)
PF07944
(Glyco_hydro_127)
3 LEU A 546
LEU A 569
ARG A 530
None
0.63A 6fgdA-4qjyA:
undetectable
6fgdA-4qjyA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qn9 N-ACYL-PHOSPHATIDYLE
THANOLAMINE-HYDROLYZ
ING PHOSPHOLIPASE D


(Homo sapiens)
PF12706
(Lactamase_B_2)
3 LEU A 215
LEU A 191
ARG A 257
None
0.54A 6fgdA-4qn9A:
undetectable
6fgdA-4qn9A:
22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rco PUTATIVE
UNCHARACTERIZED
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 253
LEU A 282
ARG A 250
None
0.68A 6fgdA-4rcoA:
undetectable
6fgdA-4rcoA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rgt PUTATIVE
UNCHARACTERIZED
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 172
LEU A 203
ARG A 169
None
0.60A 6fgdA-4rgtA:
undetectable
6fgdA-4rgtA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tpt LIM DOMAIN KINASE 2

(Homo sapiens)
PF07714
(Pkinase_Tyr)
3 LEU A 403
LEU A 472
ARG A 364
35H  A 701 ( 4.2A)
35H  A 701 (-3.7A)
None
0.62A 6fgdA-4tptA:
undetectable
6fgdA-4tptA:
20.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4u90 GEPHYRIN

(Rattus
norvegicus)
PF00994
(MoCF_biosynth)
PF03453
(MoeA_N)
PF03454
(MoeA_C)
3 LEU A 323
LEU A 605
ARG A 670
None
0.39A 6fgdA-4u90A:
50.7
6fgdA-4u90A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y93 NON-SPECIFIC
PROTEIN-TYROSINE
KINASE,NON-SPECIFIC
PROTEIN-TYROSINE
KINASE


(Bos taurus)
PF00169
(PH)
PF00779
(BTK)
PF07714
(Pkinase_Tyr)
3 LEU A  29
LEU A  31
ARG A  49
None
0.57A 6fgdA-4y93A:
undetectable
6fgdA-4y93A:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yla AROMATIC
PRENYLTRANSFERASE


(Marinactinospora
thermotolerans)
PF11991
(Trp_DMAT)
3 LEU A 143
LEU A 224
ARG A 139
None
0.59A 6fgdA-4ylaA:
undetectable
6fgdA-4ylaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zch TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13,TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13B,TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13B


(Homo sapiens)
PF00229
(TNF)
3 LEU A 117
LEU A 111
ARG A  76
None
0.63A 6fgdA-4zchA:
undetectable
6fgdA-4zchA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zch TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13,TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13B,TUMOR NECROSIS
FACTOR LIGAND
SUPERFAMILY MEMBER
13B


(Homo sapiens)
PF00229
(TNF)
3 LEU A 267
LEU A 261
ARG A 222
None
0.64A 6fgdA-4zchA:
undetectable
6fgdA-4zchA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zi9 MCG133388, ISOFORM
CRA_T


(Mus musculus)
PF00028
(Cadherin)
PF08266
(Cadherin_2)
3 LEU A  46
LEU A  67
ARG A  43
None
0.68A 6fgdA-4zi9A:
undetectable
6fgdA-4zi9A:
23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5awm STRESS-ACTIVATED
PROTEIN KINASE JNK


(Drosophila
melanogaster)
PF00069
(Pkinase)
3 LEU A 129
LEU A 121
ARG A 125
None
0.46A 6fgdA-5awmA:
undetectable
6fgdA-5awmA:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d3i STAPHYLOCOCCAL
SUPERANTIGEN-LIKE
PROTEIN 3


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU B 271
LEU B 300
ARG B 268
None
0.66A 6fgdA-5d3iB:
undetectable
6fgdA-5d3iB:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e5u CONTACTIN-6

(Mus musculus)
PF13927
(Ig_3)
3 LEU B 181
LEU B 164
ARG B 172
None
ACY  B 401 ( 4.8A)
ACY  B 401 ( 2.6A)
0.65A 6fgdA-5e5uB:
undetectable
6fgdA-5e5uB:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fka STAPHYLOCOCCAL
ENTEROTOXIN E


(Staphylococcus
aureus)
PF01123
(Stap_Strp_toxin)
PF02876
(Stap_Strp_tox_C)
3 LEU C 163
LEU C 198
ARG C 160
None
0.59A 6fgdA-5fkaC:
undetectable
6fgdA-5fkaC:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fqe BETA-N-ACETYLGALACTO
SAMINIDASE


(Clostridium
perfringens)
PF13320
(DUF4091)
3 LEU A 506
LEU A 484
ARG A 502
None
0.64A 6fgdA-5fqeA:
undetectable
6fgdA-5fqeA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ftg CHOLINE KINASE ALPHA

(Homo sapiens)
PF01633
(Choline_kinase)
3 LEU A 414
LEU A 292
ARG A 411
None
0.67A 6fgdA-5ftgA:
undetectable
6fgdA-5ftgA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gw5 T-COMPLEX PROTEIN 1
SUBUNIT DELTA


(Saccharomyces
cerevisiae)
PF00118
(Cpn60_TCP1)
3 LEU d 150
LEU d 179
ARG d 147
None
0.68A 6fgdA-5gw5d:
2.1
6fgdA-5gw5d:
23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i4d SUPERANTIGEN-LIKE
PROTEIN


(Staphylococcus
aureus)
PF02876
(Stap_Strp_tox_C)
PF09199
(SSL_OB)
3 LEU A 301
LEU A 330
ARG A 298
None
0.64A 6fgdA-5i4dA:
undetectable
6fgdA-5i4dA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ioj HALOALKYLPHOSPHORUS
HYDROLASE


(Sphingobium sp.
TCM1)
no annotation 3 LEU A 487
LEU A 577
ARG A 503
None
0.64A 6fgdA-5iojA:
undetectable
6fgdA-5iojA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5it3 LYSINE-SPECIFIC
HISTONE DEMETHYLASE
1A


(Homo sapiens)
PF04433
(SWIRM)
3 LEU A 261
LEU A 183
ARG A 214
None
0.56A 6fgdA-5it3A:
undetectable
6fgdA-5it3A:
12.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kel EBOLA SURFACE
GLYCOPROTEIN, GP1


(Zaire
ebolavirus)
PF01611
(Filo_glycop)
3 LEU A 184
LEU A 186
ARG A  64
None
0.68A 6fgdA-5kelA:
undetectable
6fgdA-5kelA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ken EBOLA SURFACE
GLYCOPROTEIN, GP1


(Zaire
ebolavirus)
PF01611
(Filo_glycop)
3 LEU A 184
LEU A 186
ARG A  64
None
0.67A 6fgdA-5kenA:
undetectable
6fgdA-5kenA:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l3d LYSINE-SPECIFIC
HISTONE DEMETHYLASE
1A


(Homo sapiens)
PF01593
(Amino_oxidase)
PF04433
(SWIRM)
3 LEU A 261
LEU A 183
ARG A 214
None
0.48A 6fgdA-5l3dA:
undetectable
6fgdA-5l3dA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lf9 NUCLEOSIDE
DIPHOSPHATE-LINKED
MOIETY X MOTIF 22


(Homo sapiens)
no annotation 3 LEU A 102
LEU A  34
ARG A  31
None
0.48A 6fgdA-5lf9A:
undetectable
6fgdA-5lf9A:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mwr TETR FAMILY
TRANSCRIPTIONAL
REGULATOR


(Sulfolobus
acidocaldarius)
no annotation 3 LEU A 193
LEU A 137
ARG A  86
None
PTR  A 133 ( 3.6A)
PTR  A 133 ( 4.3A)
0.65A 6fgdA-5mwrA:
undetectable
6fgdA-5mwrA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oet GLUTATHIONE
SYNTHETASE-LIKE
EFFECTOR 30
(GPA-GSS30-APO)


(Globodera
pallida)
no annotation 3 LEU B 248
LEU B 302
ARG B 280
None
0.68A 6fgdA-5oetB:
undetectable
6fgdA-5oetB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tws HUMAN DNA POLYMERASE
MU


(Homo sapiens)
PF10391
(DNA_pol_lambd_f)
PF14716
(HHH_8)
PF14791
(DNA_pol_B_thumb)
PF14792
(DNA_pol_B_palm)
3 LEU A 444
LEU A 432
ARG A 492
None
0.49A 6fgdA-5twsA:
undetectable
6fgdA-5twsA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wyr TRNA
(GUANINE-N(1)-)-METH
YLTRANSFERASE


(Pseudomonas
aeruginosa)
no annotation 3 LEU A 229
LEU A 180
ARG A 232
None
0.67A 6fgdA-5wyrA:
2.5
6fgdA-5wyrA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xly CYCLIC DIGUANOSINE
MONOPHOSPHATE-BINDIN
G PROTEIN PA4608


(Pseudomonas
aeruginosa)
PF07238
(PilZ)
3 LEU B  38
LEU B 112
ARG B  99
None
0.67A 6fgdA-5xlyB:
undetectable
6fgdA-5xlyB:
14.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yti FLAGELLAR HOOK
ASSOCIATED PROTEIN
TYPE 3 FLGL


(Legionella
pneumophila)
no annotation 3 LEU A 352
LEU A  73
ARG A 348
None
0.64A 6fgdA-5ytiA:
undetectable
6fgdA-5ytiA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bgi ANOCTAMIN-1

(Mus musculus)
no annotation 3 LEU A 861
LEU A 857
ARG A 860
None
0.64A 6fgdA-6bgiA:
undetectable
6fgdA-6bgiA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bhu MULTIDRUG
RESISTANCE-ASSOCIATE
D PROTEIN 1


(Bos taurus)
no annotation 3 LEU A 824
LEU A 673
ARG A 822
None
0.67A 6fgdA-6bhuA:
undetectable
6fgdA-6bhuA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6en4 SPLICING FACTOR 3B
SUBUNIT 3


(Homo sapiens)
no annotation 3 LEU A 438
LEU A 404
ARG A 436
None
0.63A 6fgdA-6en4A:
undetectable
6fgdA-6en4A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6etz BETA-GALACTOSIDASE

(Arthrobacter
sp. 32cB)
no annotation 3 LEU A 963
LEU A 954
ARG A 947
None
0.59A 6fgdA-6etzA:
undetectable
6fgdA-6etzA:
undetectable